Showing 21 - 40 results of 248 for search '"macular degeneration"', query time: 0.06s Refine Results
  1. 21

    From cellular senescence towards age-related macular degeneration: the role of telomeres by L.K. Moshetova, O.I. Abramova, K.I. Turkina, O.P. Dmitrenko, N.S. Karpova

    Published 2020-08-01
    “…<p> <b>From cellular senescence towards age-related macular degeneration: the role of telomeres</b> </p> <p> <b>L.K. …”
    Get full text
    Article
  2. 22
  3. 23

    Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration by Ilias Zampros, Anna Praidou, Periklis Brazitikos, Panagiotis Ekonomidis, Sofia Androudi

    Published 2012-01-01
    “…Age-related macular degeneration (AMD) is the leading cause of severe visual loss and blindness over the age of 50 in developed countries. …”
    Get full text
    Article
  4. 24

    Retinal status in moderate myopia and age-related macular degeneration. Management strategies by L.K. Moshetova, I.B. Alekseev, I.V. Vorobyeva, Yu.A. Nam

    Published 2022-05-01
    “…</i> </p> <p> <i><b>Keywords</b>: myopia, age-related macular degeneration, optical coherence tomography, autofluorescence.…”
    Get full text
    Article
  5. 25

    Treatment for neovascular age-related macular degeneration: reasonable expectations of physicians and patients by A.B. Durasov

    Published 2021-09-01
    “…Treatment for neovascular age-related macular degeneration: reasonable expectations of physicians and patients. …”
    Get full text
    Article
  6. 26

    Different Strategies for the Treatment of Age-Related Macular Degeneration in China: An Economic Evaluation by Bin Wu, Jin Li, Houwen Lin, Haixiang Wu

    Published 2016-01-01
    “…To assess the cost-effectiveness of bevacizumab compared to ranibizumab, verteporfin photodynamic therapy (PDT), and usual care for the treatment of age-related macular degeneration (AMD) in China. Methods. A Markov model was developed according to patient visual acuity (VA) in the better-seeing eye (Snellen scale). …”
    Get full text
    Article
  7. 27
  8. 28
  9. 29

    Long-Term Outcomes of Rheohaemapheresis in the Treatment of Dry Form of Age-Related Macular Degeneration by Jan Studnička, Eva Rencová, Milan Bláha, Pavel Rozsíval, Miriam Lánská, Vladimír Bláha, Jan Němčanský, Hana Langrová

    Published 2013-01-01
    “…Determining long-term effects of rheohaemapheresis on the dry form of age-related macular degeneration. Methods. This study evaluates 19 patients, average age of 67.6 years, treated with rheohaemapheresis and 18 patients, average age of 72.8 years, comprising the control group. …”
    Get full text
    Article
  10. 30

    EFFICIENT RETINAL IMAGE SEGMENTATION BY U-NET FOR AGE-RELATED MACULAR DEGENERATION DIAGNOSIS by S Sujatha, Pramod Pandey, D Gnana Rajesh

    Published 2024-12-01
    Subjects: “…biomedical imaging, age-related macular degeneration, deep learning, image analysis, macular deterioration…”
    Get full text
    Article
  11. 31

    Association of sildenafil use with age-related macular degeneration: a retrospective cohort study by Nicola Jaime Adderley, Krishnarajah Nirantharakumar, Anuradhaa Subramanian, Alastair K Denniston, Wen Hwa Lee, Ji Eun Diana Han, Jesse Coker

    Published 2024-04-01
    “…Objective Despite significant advances in clinical care and understanding of the underlying pathophysiology, age-related macular degeneration (AMD)—a major cause of global blindness—lacks effective treatment to prevent the irreversible degeneration of photoreceptors leading to central vision loss. …”
    Get full text
    Article
  12. 32

    Treatment of the dry form of age-related macular degeneration: the studied present and promising future by N.G. Glazko, O.A. Kanaeva, M.H. Rabadanova

    Published 2022-11-01
    “…Treatment of the dry form of age-related macular degeneration: the studied present and promising future. …”
    Get full text
    Article
  13. 33
  14. 34
  15. 35
  16. 36

    Carotenoids in the treatment of age-related macular degeneration: a drug delivery system does matter by M.L. Maximov, Zh.G. Oganezova, I.D. Kanner, Voznesenskaya A.A

    Published 2023-03-01
    “…Carotenoids in the treatment of age-related macular degeneration: a drug delivery system does matter. …”
    Get full text
    Article
  17. 37

    Serum lipids mediate the association of per- and polyfluoroalkyl substances exposure and age-related macular degeneration. by Xiaodong Chen, Jiaqi Li, Ningda Xu, Xuewei Li, Jiarui Li, Qianwen Guo, Jia Zhang, Heng Miao, Lvzhen Huang

    Published 2025-01-01
    “…<h4>Background</h4>This study aims to investigate the connection between serum lipids, per- and polyfluoroalkyl substances (PFAS), and age-related macular degeneration (AMD) risk and assess whether serum lipids mediate the association between PFAS and AMD.…”
    Get full text
    Article
  18. 38

    Does Cataract Surgery Improve the Progression of Age-Related Macular Degeneration? A Meta-Analysis by Yuanyuan Liu, Qinhua Cai

    Published 2020-01-01
    “…Cataract and age-related macular degeneration (AMD) are the common causes of blindness in the elderly. …”
    Get full text
    Article
  19. 39
  20. 40

    En Face OCT Imaging for the Diagnosis of Outer Retinal Tubulations in Age-Related Macular Degeneration by Benjamin Wolff, Alexandre Matet, Vivien Vasseur, José-Alain Sahel, Martine Mauget-Faÿsse

    Published 2012-01-01
    “…Outer retinal tubulations (ORTs) in age-related macular degeneration (AMD) are a recent finding evidenced by spectral-domain OCT. …”
    Get full text
    Article